Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates
- PMID: 34043398
- PMCID: PMC8376089
- DOI: 10.1037/pha0000457
Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates
Abstract
Cannabis and synthetic cannabinoids are abused in spite of possible adverse health consequences. The current study investigated the reinforcing effects of an ecologically relevant mode of administration (inhalation) of delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, and three synthetic cannabinoids detected in synthetic cannabinoid products (JWH-018, JWH-073, and HU-210) in non-human primates (NHPs). Male and female (N = 4 each) rhesus macaques were trained to inhale warm air via a metal stem to receive a candy reinforcer, an alcohol aerosol vehicle was then paired with the candy. Dose-dependent responding for inhaled aerosols of THC (2.0-16.0 μg/kg/inhalation), JWH-018 (0.2-1.6 μg/kg/inhalation), JWH-073 (2.0-8.0 μg/kg/inhalation), and HU-210 (1.0-8.0 μg/kg/inhalation) was established using a fixed-ratio five schedule of reinforcement and compared to vehicle (alcohol) self-administration. Dose-dependent responding for inhaled heroin (25.0-100.0 μg/kg/inhalation), a known reinforcer in NHPs, was also established. Responding approximated vehicle levels for many drug doses tested, but at least half of the monkeys responded for ≥ one dose of each cannabinoid and heroin above vehicle, with the exception of THC. Drug deliveries calculated as percent vehicle followed a prototypical inverted-U shaped dose-response curve for cannabinoids and heroin except for THC and JWH-018 (in males). Grouped data according to sex demonstrated that peak percent of vehicle reinforcers earned for THC was greater in males than females, whereas peak percent of vehicle reinforcers earned for JWH-018, HU-210, and heroin were greater in females than males. These findings indicate minimal reinforcing effects of CB1 receptor agonists when self-administered by NHPs via aerosol inhalation. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Figures






Similar articles
-
Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.J Pharmacol Exp Ther. 2012 Sep;342(3):843-9. doi: 10.1124/jpet.112.196444. Epub 2012 Jun 20. J Pharmacol Exp Ther. 2012. PMID: 22718500 Free PMC article.
-
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.Pharmacol Biochem Behav. 2014 Sep;124:40-7. doi: 10.1016/j.pbb.2014.05.010. Epub 2014 May 21. Pharmacol Biochem Behav. 2014. PMID: 24857780 Free PMC article.
-
Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.Neuropsychopharmacology. 2005 Nov;30(11):2046-57. doi: 10.1038/sj.npp.1300754. Neuropsychopharmacology. 2005. PMID: 15870833
-
The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110301. doi: 10.1016/j.pnpbp.2021.110301. Epub 2021 Mar 17. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33741446 Review.
-
Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.Clin Pharmacol Ther. 2015 Jun;97(6):562-4. doi: 10.1002/cpt.114. Epub 2015 Apr 17. Clin Pharmacol Ther. 2015. PMID: 25788107 Review.
Cited by
-
Unveiling the link between chronic pain and misuse of opioids and cannabis.J Neural Transm (Vienna). 2024 May;131(5):563-580. doi: 10.1007/s00702-024-02765-3. Epub 2024 Apr 3. J Neural Transm (Vienna). 2024. PMID: 38570361 Review.
-
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.Pharmacol Biochem Behav. 2024 Oct;243:173836. doi: 10.1016/j.pbb.2024.173836. Epub 2024 Jul 26. Pharmacol Biochem Behav. 2024. PMID: 39067531 Review.
References
-
- Atwood BK, Huffman J, Straiker A, & Mackie K (2010). JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB 1 receptor agonist: ‘Spice’ contains a potent cannabinoid agonist. British Journal of Pharmacology, 160(3), 585–593. 10.1111/j.1476-5381.2009.00582.x - DOI - PMC - PubMed
-
- Boni JP, Barr WH, & Martin BR (1991). Cocaine inhalation in the rat: Pharmacokinetics and cardiovascular response. The Journal of Pharmacology and Experimental Therapeutics, 257(1), 307–315. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources